Device Trial Radar · NCT03156010
Oculomotor Assessment of Traumatic Brain Injury (TBI)
Last checked: Nov 19, 2026Latest source record: Aug 23, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
201
Actual
Start
Sep 18, 2017
Primary completion
Apr 19, 2023
Study completion Apr 19, 2023
Sponsor
- Lead sponsor
- Walter Reed National Military Medical CenterFederal agency
- Sponsor type
- Federal agency
- Collaborators
- Neurolign; Sync-Think, Inc.; Oculogica, Inc.; TBICoE; United States Department of Defense
- First posted
- May 16, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of the proposed study is to compare the sensitivity and specificity of three oculomotor test devices in normal subjects versus subjects with history of TBI. The study is designed as a prospective research project in which a group of 120 normal controls without a history of TBI will be compared to another group of 120 participants (total of 240) who have a confirmed history of TBI. Each participant will complete the TBI assessment protocol for each of three separate devices (Neuro Kinetics, SyncThink, and Oculogica). The order of the devices will be counter-balanced across participants. Participants will also be screened for vestibular migraine and visual vertigo, which are two conditions that influence oculo-vestibular perception in normal and TBI patients and might influence the results from the three oculomotor devices. Data from each device will be utilized to perform AUC analyses to determine the respective sensitivity and specificity for each.
Conditions
- Traumatic Brain Injury
Interventions
Neuro Kinetics IPASDevice
Testing with PAS device
Oculogica EyeBoxDevice
Testing with Oculogica EyeBox device
SyncThink EyeSync DeviceDevice
Testing with SyncThink EyeSync device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area Under the Curve (AUC)Time frame: Single test session (1.5 hours) - all testing performed at time of study enrollment, will be reported at conclusion of data collection as all data is required to generate AUCs.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
National Intrepid Center of Excellence
Bethesda, Maryland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.